PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 30 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $66,000 | -33.3% | 178,100 | -31.9% | 0.00% | – |
Q1 2016 | $99,000 | +141.5% | 261,719 | +241.2% | 0.00% | – |
Q2 2015 | $41,000 | +70.8% | 76,699 | +161.2% | 0.00% | – |
Q1 2015 | $24,000 | +33.3% | 29,361 | +29.2% | 0.00% | – |
Q4 2014 | $18,000 | -5.3% | 22,725 | +4.5% | 0.00% | – |
Q2 2014 | $19,000 | – | 21,748 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HOME FEDERAL BANK OF TENNESSEE | 100,000 | $6,000 | 0.00% |
LEE DANNER & BASS INC | 50,000 | $3,000 | 0.00% |
Ancora Advisors LLC | 14,650 | $1,000 | 0.00% |
Diversified Trust Co | 50,000 | $3,000 | 0.00% |
CAPTRUST FINANCIAL ADVISORS | 57,659 | $3,000 | 0.00% |
ACADEMY CAPITAL MANAGEMENT INC/TX | 20,000 | $1,000 | 0.00% |
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |